RESEARCH WITH IMPACT
Now is the time to push the boundaries of knowledge and innovation. Our research is at the forefront of life-saving drug discoveries and health policy developments. We want to change the world and you can help us.
A QUICK GLANCE AT WHAT WE’ RE WORKING ON …
HEALTH SERVICES
Pharmacists are an important part of the healthcare system. We’ re focusing on pharmacy practice research that optimise the level of care, reduce healthcare disparity and improve health outcomes.
GUT MICROBIOME
We study how drugs and food interact with the gut microbiome to gain insights into how variation in gut microbes leads to the risk of diseases.
WOUND CARE
We have developed a novel all-in-one dressing that promotes blood clot formation, accelerates wound healing and reduces scar formation. Clinical trials have started, in collaboration with Universiti Malaya Medical Centre and the Malaysian Palm Oil Board.
HEALTH ECONOMICS
We’ re examining the validity of current measurements and valuations of health with the goal of promoting cost efficiency and improved outcomes of new healthcare interventions. Such research will aid planners and policymakers in making broad decisions on healthcare.
What I enjoyed most at Monash was the vibrant research culture, where I could engage in discussions with supervisors and peers, brainstorm ideas, and support one another. The open and collaborative environment, free from excessive red tape and hierarchy, allowed us to explore areas of interest freely and develop our research with flexibility.”
DR RUTH SIM
Bachelor of Pharmacy Doctor of Philosophy( Pharmacy) Lecturer, Monash University Malaysia
Ruth ' s thesis evaluated the clinical effectiveness and economic impact of antidiabetic medications, focusing on cardiovascular and renal outcomes. Her findings could help optimise care and inform resource allocation and reimbursement policies. She aims to establish herself as an epidemiologist, using technology to enhance disease tracking and optimise cost-effective, sustainable treatments in Malaysia and Southeast Asia.
NEUROSCIENCE
We’ re studying the genetic and molecular mechanisms of neurological disorders such as Parkinson’ s and Alzheimer’ s diseases. We’ re also evaluating potential therapeutic agents for disease intervention through advance in silico and in vitro studies.
DRUG DELIVERY SYSTEMS
There’ s an abundance of natural compounds with proven therapeutic effects that are often limited by compound properties and inappropriate formulations. We’ re improving the formulation of such compounds to overcome poor solubility, absorption and bioavailability.
17